MX2015012175A - Tratamiento de la deficiencia de la hormona del crecimiento pediatrica con analogos de la hormona del crecimiento humano. - Google Patents
Tratamiento de la deficiencia de la hormona del crecimiento pediatrica con analogos de la hormona del crecimiento humano.Info
- Publication number
- MX2015012175A MX2015012175A MX2015012175A MX2015012175A MX2015012175A MX 2015012175 A MX2015012175 A MX 2015012175A MX 2015012175 A MX2015012175 A MX 2015012175A MX 2015012175 A MX2015012175 A MX 2015012175A MX 2015012175 A MX2015012175 A MX 2015012175A
- Authority
- MX
- Mexico
- Prior art keywords
- growth hormone
- pediatric
- xten
- treatment
- therapy
- Prior art date
Links
- 206010056438 Growth hormone deficiency Diseases 0.000 title abstract 2
- 102000002265 Human Growth Hormone Human genes 0.000 title abstract 2
- 108010000521 Human Growth Hormone Proteins 0.000 title abstract 2
- 239000000854 Human Growth Hormone Substances 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 3
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361776618P | 2013-03-11 | 2013-03-11 | |
| US201361810786P | 2013-04-11 | 2013-04-11 | |
| US201361835002P | 2013-06-14 | 2013-06-14 | |
| US201361880701P | 2013-09-20 | 2013-09-20 | |
| US201361911731P | 2013-12-04 | 2013-12-04 | |
| US201461931987P | 2014-01-27 | 2014-01-27 | |
| US201461948457P | 2014-03-05 | 2014-03-05 | |
| PCT/US2014/022850 WO2014164568A1 (en) | 2013-03-11 | 2014-03-10 | Treatment of pediatric growth hormone deficiency with human growth hormone analogues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015012175A true MX2015012175A (es) | 2016-01-12 |
Family
ID=51658905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012175A MX2015012175A (es) | 2013-03-11 | 2014-03-10 | Tratamiento de la deficiencia de la hormona del crecimiento pediatrica con analogos de la hormona del crecimiento humano. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20160158321A1 (enExample) |
| EP (1) | EP2968451A4 (enExample) |
| JP (3) | JP2016514132A (enExample) |
| KR (1) | KR20150124955A (enExample) |
| CN (1) | CN105209055A (enExample) |
| AU (1) | AU2014249258A1 (enExample) |
| BR (1) | BR112015022257A8 (enExample) |
| CA (1) | CA2900949A1 (enExample) |
| CL (1) | CL2015002456A1 (enExample) |
| EA (1) | EA201591529A1 (enExample) |
| HK (1) | HK1216617A1 (enExample) |
| IL (1) | IL240392A0 (enExample) |
| MX (1) | MX2015012175A (enExample) |
| PH (1) | PH12015502063A1 (enExample) |
| SG (1) | SG11201506732YA (enExample) |
| WO (1) | WO2014164568A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9849188B2 (en) | 2009-06-08 | 2017-12-26 | Amunix Operating Inc. | Growth hormone polypeptides and methods of making and using same |
| WO2016109823A1 (en) * | 2015-01-02 | 2016-07-07 | Amunix Operation Inc. | Treatment of pediatric growth hormone deficiency with human growth hormone analogues |
| AU2016214265A1 (en) | 2015-02-03 | 2017-08-17 | Apple Inc. | Family sleep monitoring system |
| IL319047A (en) | 2015-08-28 | 2025-04-01 | Amunix Operating Inc | Chimeric polypeptide composition and methods for its preparation and use |
| WO2017136583A1 (en) | 2016-02-02 | 2017-08-10 | Versartis, Inc. | Growth hormone treatment adherence system |
| JP6896749B2 (ja) * | 2016-02-17 | 2021-06-30 | ジェネクシン・インコーポレイテッドＧｅｎｅｘｉｎｅ， Ｉｎｃ． | 組換えｈＧＨを含む、成長ホルモン欠乏を治療するための薬学組成物 |
| JOP20190019A1 (ar) * | 2016-08-30 | 2019-02-12 | Genexine Inc | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) |
| US10288629B1 (en) * | 2017-12-19 | 2019-05-14 | Aeterna Zentaris, Inc. | Method of assessing growth hormone deficiency in humans by a macimorelin containing composition |
| AU2018393111B2 (en) | 2017-12-21 | 2025-07-10 | Amunix Pharmaceuticals, Inc. | Release segments and binding compositions comprising same |
| US11903683B2 (en) | 2018-08-03 | 2024-02-20 | Chelak Medical Solutions Inc | Non-barometric determination of hemodynamic effects of cardiac arrhythmias using signals sensed by an implantable device |
| RU2753191C2 (ru) * | 2019-09-26 | 2021-08-12 | Федеральное государственное бюджетное учреждение науки Институт Биологии Развития им. Н.К. Кольцова Российской Академии Наук | Новый рекомбинантный аналог гормона роста пролонгированного действия |
| WO2021136223A1 (en) | 2019-12-31 | 2021-07-08 | Beijing Ql Biopharmaceutical Co., Ltd. | Fusion proteins of glp-1 and gdf15 and conjugates thereof |
| CN113728013B (zh) | 2020-01-11 | 2022-06-14 | 北京质肽生物医药科技有限公司 | Glp-1和fgf21的融合蛋白的缀合物 |
| KR102599111B1 (ko) * | 2020-01-31 | 2023-11-07 | 울산대학교 산학협력단 | 인슐린유사성장인자-1 융합단백질 및 이의 용도 |
| EP4185866A1 (en) * | 2020-07-22 | 2023-05-31 | Aeterna Zentaris GmbH | A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin |
| KR20230083294A (ko) | 2020-09-30 | 2023-06-09 | 베이징 큐엘 바이오파마슈티컬 컴퍼니 리미티드 | 폴리펩타이드 접합체 및 사용 방법 |
| CA3252113A1 (en) | 2022-03-30 | 2023-10-05 | Beijing Ql Biopharmaceutical Co., Ltd. | Liquid pharmaceutical compositions of polypeptide conjugates and their methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3178835B1 (en) * | 2009-02-03 | 2019-04-10 | Amunix Pharmaceuticals, Inc. | Extended recombinant polypeptides and compositions comprising same |
| ES2544982T3 (es) * | 2009-09-02 | 2015-09-07 | Merck Serono S.A. | Método para predecir el nivel de respuesta al crecimiento |
| BR112014030404A2 (pt) * | 2012-06-05 | 2017-06-27 | Amunix Operating Inc | proteína de fusão hgh-xten e seu uso no tratamento da deficiência de hormônio do crescimento |
-
2014
- 2014-03-10 US US14/771,445 patent/US20160158321A1/en not_active Abandoned
- 2014-03-10 JP JP2016501088A patent/JP2016514132A/ja not_active Withdrawn
- 2014-03-10 WO PCT/US2014/022850 patent/WO2014164568A1/en not_active Ceased
- 2014-03-10 EA EA201591529A patent/EA201591529A1/ru unknown
- 2014-03-10 KR KR1020157023667A patent/KR20150124955A/ko not_active Withdrawn
- 2014-03-10 HK HK16104695.2A patent/HK1216617A1/zh unknown
- 2014-03-10 AU AU2014249258A patent/AU2014249258A1/en not_active Abandoned
- 2014-03-10 EP EP14780175.7A patent/EP2968451A4/en not_active Withdrawn
- 2014-03-10 BR BR112015022257A patent/BR112015022257A8/pt active Search and Examination
- 2014-03-10 CN CN201480011475.9A patent/CN105209055A/zh active Pending
- 2014-03-10 CA CA2900949A patent/CA2900949A1/en not_active Abandoned
- 2014-03-10 SG SG11201506732YA patent/SG11201506732YA/en unknown
- 2014-03-10 MX MX2015012175A patent/MX2015012175A/es unknown
-
2015
- 2015-08-06 IL IL240392A patent/IL240392A0/en unknown
- 2015-09-02 CL CL2015002456A patent/CL2015002456A1/es unknown
- 2015-09-11 PH PH12015502063A patent/PH12015502063A1/en unknown
-
2017
- 2017-03-02 JP JP2017039625A patent/JP2017101074A/ja not_active Withdrawn
-
2019
- 2019-01-17 JP JP2019005944A patent/JP2019056013A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201506732YA (en) | 2015-09-29 |
| EP2968451A4 (en) | 2017-01-04 |
| EP2968451A1 (en) | 2016-01-20 |
| KR20150124955A (ko) | 2015-11-06 |
| IL240392A0 (en) | 2015-09-24 |
| CL2015002456A1 (es) | 2016-05-27 |
| JP2019056013A (ja) | 2019-04-11 |
| HK1216617A1 (zh) | 2016-11-25 |
| CN105209055A (zh) | 2015-12-30 |
| US20160158321A1 (en) | 2016-06-09 |
| PH12015502063A1 (en) | 2016-01-25 |
| WO2014164568A1 (en) | 2014-10-09 |
| JP2017101074A (ja) | 2017-06-08 |
| JP2016514132A (ja) | 2016-05-19 |
| CA2900949A1 (en) | 2014-10-09 |
| BR112015022257A8 (pt) | 2018-01-23 |
| EA201591529A1 (ru) | 2016-04-29 |
| AU2014249258A1 (en) | 2015-08-27 |
| BR112015022257A2 (pt) | 2017-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015502063A1 (en) | Treatment of pediatric growth hormone deficiency with human growth hormone analogues | |
| BR112015026325A2 (pt) | dosagem oral de compostos glp-1 | |
| MY188139A (en) | Sodium channel modulators for the treatment of pain | |
| ZA202406617B (en) | Insulin containing pharmaceutical compositions | |
| PH12014502738A1 (en) | High-xten fusion protein and its use in the treatment of growth hormone deficiency | |
| SG10201805552PA (en) | Sodium channel modulators for the treatment of pain and diabetes | |
| BR112014031806A8 (pt) | método para tratamento de câncer positivo para gd2 | |
| MX2015012322A (es) | Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunes. | |
| MX2021008207A (es) | Proteínas de fusión multifuncionales y usos de las mismas. | |
| MD20150120A2 (ro) | Tratamentul bolilor neurodegenerative şi miopatice de agregare proteică prin administrarea parenterală a trehalozei | |
| MY191380A (en) | Stabilized fixed dose drug composition having mometasone and olopatadine | |
| EA201590933A1 (ru) | Новые перорально биодоступные соединения, модулирующие контроль дыхания, и способы их использования | |
| MX2015011905A (es) | Uso de levocetirizina y montelukast en el tratamiento de la vasculitis. | |
| WO2016109823A8 (en) | Treatment of pediatric growth hormone deficiency with human growth hormone analogues | |
| MX382776B (es) | Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica. | |
| JOP20190019A1 (ar) | تركيبة صيدلانية لعلاج نقص في هرمون نمو يحتوي على بروتين اندماجي لهرمون نمو بشري (hGH) | |
| EA201691055A1 (ru) | Препараты и способы лечения gd2-положительного рака | |
| MY193963A (en) | Composition for treating joint diseases and kit containing same | |
| MX2017001433A (es) | Sistema de bioprocesamiento a microescala y metodo para fabricacion de proteina a partir de sangre humana. | |
| MX2022007738A (es) | Procesos e intermedios sinteticos. | |
| MX2014014817A (es) | Compuestos para el tratamiento de inflamacion y dolor. | |
| WO2016115442A3 (en) | Therapeutic protein formulations | |
| UA69674U (ru) | Способ лечения больных на эритематозно-бульозной рожей | |
| EA201990553A1 (ru) | Применение придопидина для лечения ухудшения функциональной способности | |
| UA65569U (ru) | Способ коррекции обмена веществ у собак при лечении токсокарозной инвазии |